Cuproptosis-related lncRNA signatures predict prognosis and immune relevance of kidney renal papillary cell carcinoma

Cuproptosis-related lncRNA signatures predict prognosis and immune relevance of kidney renal papillary cell carcinoma

Kidney renal papillary cell carcinoma (KIRP) has a high mortality rate and a poor prognosis. Cu concentrations differed significantly between renal cancer tissues and adjacent normal tissues. Cuproptosis is a newly identified cell death. Long non-coding RNAs (lncRNAs) play a crucial role in the prog...

Бүрэн тодорхойлолт

Номзүйн дэлгэрэнгүй
Үндсэн зохиолчид:	Tongjin Xie, Bin Liu, Dongbo Liu, Yusong Zhou, Qingping Yang, Dai Wang, Mengjie Tang, Wei Liu
Формат:	Өгүүллэг
Хэл сонгох:	English
Хэвлэсэн:	Frontiers Media S.A. 2022-12-01
Цуврал:	Frontiers in Pharmacology
Нөхцлүүд:	lncRNA cuproptosis KIRP prognosis immune relevance
Онлайн хандалт:	https://www.frontiersin.org/articles/10.3389/fphar.2022.1103986/full

Ижил төстэй зүйлс

A novel cuproptosis-related lncRNA signature predicts the prognosis and immune landscape in bladder cancer
-н: Yuchen Bai, зэрэг
Хэвлэсэн: (2022-11-01)

A novel signature to guide osteosarcoma prognosis and immune microenvironment: Cuproptosis-related lncRNA
-н: Mingyi Yang, зэрэг
Хэвлэсэн: (2022-07-01)

Ferroptosis-Related lncRNA to Predict the Clinical Outcomes and Molecular Characteristics of Kidney Renal Papillary Cell Carcinoma
-н: Yubo Gong, зэрэг
Хэвлэсэн: (2024-02-01)

Identification of cuproptosis-related lncRNA prognostic signature for osteosarcoma
-н: Binfeng Liu, зэрэг
Хэвлэсэн: (2022-10-01)

A cuproptosis-related lncRNA signature for predicting prognosis and immune response in hepatocellular carcinoma
-н: Jingyi Wu, зэрэг
Хэвлэсэн: (2023-09-01)

Cuproptosis related lncRNA signature as a prognostic and therapeutic biomarker in osteosarcoma immunity
-н: Ziwei Gao, зэрэг
Хэвлэсэн: (2025-01-01)

Cuproptosis-related lncRNA signatures: Predicting prognosis and evaluating the tumor immune microenvironment in lung adenocarcinoma
-н: Pengpeng Zhang, зэрэг
Хэвлэсэн: (2023-01-01)

Prognosis and immune response of a cuproptosis-related lncRNA signature in low grade glioma
-н: Yifan Xu, зэрэг
Хэвлэсэн: (2022-10-01)

Cuproptosis-related lncRNA: Prediction of prognosis and subtype determination in clear cell renal cell carcinoma
-н: Youlong Huili, зэрэг
Хэвлэсэн: (2022-08-01)

Construction of five cuproptosis-related lncRNA signature for predicting prognosis and immune activity in skin cutaneous melanoma
-н: Xiaojing Yang, зэрэг
Хэвлэсэн: (2022-09-01)

Identification and validation of a novel cuproptosis-related lncRNA gene signature to predict prognosis and immune response in bladder cancer
-н: Jia Chen, зэрэг
Хэвлэсэн: (2022-12-01)

Identification and Validation of Cuproptosis-Related LncRNA Signatures in the Prognosis and Immunotherapy of Clear Cell Renal Cell Carcinoma Using Machine Learning
-н: Zhixun Bai, зэрэг
Хэвлэсэн: (2022-12-01)

Identification of novel cuproptosis-related lncRNA signatures to predict the prognosis and immune microenvironment of breast cancer patients
-н: Zi-Rong Jiang, зэрэг
Хэвлэсэн: (2022-09-01)

Identification of a novel prognostic cuproptosis-associated LncRNA signature for predicting prognosis and immunotherapy response in patients with esophageal cancer
-н: Xinhai Sun, зэрэг
Хэвлэсэн: (2024-05-01)

Prognostic Significance and Immune Landscape of a Cuproptosis-Related LncRNA Signature in Ovarian Cancer
-н: Min Zhou, зэрэг
Хэвлэсэн: (2024-11-01)

A novel cuproptosis-related lncRNAs signature predicts prognostic and immune of bladder urothelial carcinoma
-н: Zheng Zhou, зэрэг
Хэвлэсэн: (2023-03-01)

Comprehensive analysis of cuproptosis-related lncRNAs signature to predict prognosis in bladder urothelial carcinoma
-н: Shusheng Zhu, зэрэг
Хэвлэсэн: (2023-07-01)

In Silico Identification and Validation of Cuproptosis-Related LncRNA Signature as a Novel Prognostic Model and Immune Function Analysis in Colon Adenocarcinoma
-н: Yue Wang, зэрэг
Хэвлэсэн: (2022-09-01)

Comprehensive analysis of a novel cuproptosis-related lncRNA signature associated with prognosis and tumor matrix features to predict immunotherapy in soft tissue carcinoma
-н: Binfeng Liu, зэрэг
Хэвлэсэн: (2022-12-01)

Construction and validation of a cuproptosis-related five-lncRNA signature for predicting prognosis, immune response and drug sensitivity in breast cancer
-н: Chun Li, зэрэг
Хэвлэсэн: (2023-07-01)

Cuproptosis-related lncRNA signature for prognostic prediction in patients with acute myeloid leukemia
-н: Yidong Zhu, зэрэг
Хэвлэсэн: (2023-02-01)

Development and validation of a cuproptosis-related lncRNA model correlated to the cancer-associated fibroblasts enable the prediction prognosis of patients with osteosarcoma
-н: Xiaoping Wang, зэрэг
Хэвлэсэн: (2023-02-01)

Signature of seven cuproptosis-related lncRNAs as a novel biomarker to predict prognosis and therapeutic response in cervical cancer
-н: Xinyu Liu, зэрэг
Хэвлэсэн: (2022-09-01)

A novel cuproptosis-related LncRNA signature: Prognostic and therapeutic value for low grade glioma
-н: Jun Wen, зэрэг
Хэвлэсэн: (2023-01-01)

Cuproptosis-related lncRNA signature as a prognostic tool and therapeutic target in diffuse large B cell lymphoma
-н: Xiaoran Bai, зэрэг
Хэвлэсэн: (2024-06-01)

Construction and validation of a cuproptosis-related lncRNA signature as a novel and robust prognostic model for colon adenocarcinoma
-н: Miaorong Xu, зэрэг
Хэвлэсэн: (2022-07-01)

Cuproptosis-related LncRNAs signature as biomarker of prognosis and immune infiltration in pancreatic cancer
-н: Hui Chen, зэрэг
Хэвлэсэн: (2023-01-01)

Identification and validation of cuproptosis-related LncRNA signatures as a novel prognostic model for head and neck squamous cell cancer
-н: Xiajing Liu, зэрэг
Хэвлэсэн: (2022-11-01)

Prognostic analysis of hepatocellular carcinoma based on cuproptosis -associated lncRNAs
-н: Mingwei Wei, зэрэг
Хэвлэсэн: (2024-04-01)

Construction and comprehensive analysis of a curoptosis-related lncRNA signature for predicting prognosis and immune response in cervical cancer
-н: Li Liu, зэрэг
Хэвлэсэн: (2023-01-01)

Prognosis and personalized treatment prediction in lung adenocarcinoma: An in silico and in vitro strategy adopting cuproptosis related lncRNA towards precision oncology
-н: Chao Ma, зэрэг
Хэвлэсэн: (2023-02-01)

Cuproptosis-Associated lncRNA Establishes New Prognostic Profile and Predicts Immunotherapy Response in Clear Cell Renal Cell Carcinoma
-н: Shengxian Xu, зэрэг
Хэвлэсэн: (2022-07-01)

Based on cuproptosis-related lncRNAs, a novel prognostic signature for colon adenocarcinoma prognosis, immunotherapy, and chemotherapy response
-н: Chong Li, зэрэг
Хэвлэсэн: (2023-06-01)

Prediction of immune infiltration and prognosis for patients with cholangiocarcinoma based on a cuproptosis-related lncRNA signature
-н: Hong-Fei Yao, зэрэг
Хэвлэсэн: (2024-01-01)

Construction of a cuproptosis-associated lncRNA prognostic signature for bladder cancer and experimental validation of cuproptosis-related lncRNA UBE2Q1-AS1
-н: Junlin Shen, зэрэг
Хэвлэсэн: (2023-08-01)

Identification of a novel cuproptosis-associated lncRNA model that can improve prognosis prediction in uterine corpus endometrial carcinoma
-н: Bohan Li, зэрэг
Хэвлэсэн: (2023-12-01)

Development and validation of cuproptosis-related lncRNA signatures for prognosis prediction in colorectal cancer
-н: Lin Pang, зэрэг
Хэвлэсэн: (2023-03-01)

Cuproptosis-associated lncRNAs discern prognosis and immune microenvironment in sarcoma victims
-н: Binxiang Chu, зэрэг
Хэвлэсэн: (2022-12-01)

A cuproptosis-related LncRNA signature: Integrated analysis associated with biochemical recurrence and immune landscape in prostate cancer
-н: Lei Ren, зэрэг
Хэвлэсэн: (2023-02-01)

A cuproptosis-related lncRNA signature-based prognostic model featuring on metastasis and drug selection strategy for patients with lung adenocarcinoma
-н: Mengzhe Zhang, зэрэг
Хэвлэсэн: (2023-09-01)